Bronchitis

12/01/1998 - "Because the results of individual clinical trials have been mixed, we conducted a meta-analysis to determine whether antibiotics are effective treatment for acute bronchitis. "
05/01/2015 - "Are antibiotics effective in the treatment of acute bronchitis?"
07/01/2000 - "One patient showed post-influenzal bronchitis which was effectively treated by antibiotics. "
12/01/1998 - "Antibiotics may be modestly effective for a minority of patients with acute bronchitis. "
12/01/1998 - "Are antibiotics effective treatment for acute bronchitis? "

02/01/2014 - "To date, no controlled clinical trials have demonstrated effective treatment of plastic bronchitis. "
03/01/2013 - "The use of aerosolized t-PA for the treatment of plastic bronchitis has been reported to be safe and effective in 4 cases but no consistent regimen, dose, or duration of treatment has been established. "
12/01/2010 - "After bronchoscopic extraction of casts and antiviral treatment, all of the patients recovered, and there has been no recurrence of the plastic bronchitis. "
01/01/2004 - "Following implantation of an atrial pacemaker, which restored atrioventricular (A-V) synchrony, the patient's hemodynamics greatly improved and his plastic bronchitis resolved."
07/01/2014 - "To study the clinical features and pathogens of plastic bronchitis in children. "

01/01/1974 - "[The clinical effects of amoxicillin in the management of chronic bronchitis]."
11/01/2008 - "Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial."
03/01/2006 - "A randomized, double-blind, controlled clinical trial was carried out in 140 infants 1-2 y of age distributed into two groups after a 1-wk amoxicillin treatment (50 mg/kg/d) for acute bronchitis. "
09/01/1991 - "A nosocomial outbreak of acute bronchitis due to amoxycillin-resistant, non-typable Haemophilus influenzae occurred in a 23-bed unit, housing patients with respiratory disorders. "
03/01/1987 - "Fifty patients with moderate or severe bronchitis were randomly allocated into groups receiving orally either 1000 mg amoxycillin twice daily or 750 mg three times daily. "

01/01/1983 - "In conclusion, the study showed that the enteric-coated erythromycin as pellets, given twice or four times daily for 10 days, was well tolerated and equally effective in acute bronchitis. "
08/01/1986 - "To assess the efficacy of erythromycin in treating acute bronchitis, 52 adults were enrolled in a randomized trial comparing a one-week course of erythromycin with placebo. "
03/01/1983 - "Acute bronchitis-efficacy of erythromycin base (Ery-Max) administered twice or four times daily."
06/01/1996 - "The objectives of this study were to determine the effectiveness of erythromycin treatment in patients with acute bronchitis and to determine whether a newly developed rapid M pneumoniae antibody test is useful in predicting which patients will respond to therapy. "
08/01/1987 - "A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis."

01/01/1981 - "This study was undertaken to evaluate the efficacy of a fixed combination of amoxicillin and clavulanic acid in 33 patients with chronic or recurrent respiratory tract infections (R.T.I.), mainly bronchitis. "
03/01/2013 - "Children with "chronic wet cough" (presumed protracted bacterial bronchitis) respond to 14 days of amoxicillin clavulanate."
01/01/1997 - "Amoxyclav (amoxycillin/potassium clavulanate, A/PC) was used in the treatment of 55 children with acute bronchitis and pneumonia. "
12/01/2007 - "Following preliminary clinical studies in bronchitis and urinary tract infections, amoxicillin/clavulanate therapy was investigated in a wide range of infections and proved to demonstrate a high level of clinical efficacy. "
01/01/1998 - "Both treatments improved the signs and symptoms of bronchitis, and overall clinical success rates were equivalent for patients treated with ceftibuten (211 of 252 [84%]) and amoxicillin-clavulanate (93 of 117 [79%]) (95% confidence interval [CI], -4.5% to 13.6%). "

01/01/2014 - "Nine participants with neutrophilic bronchitis had a potentially pathogenic bacteria isolated and the median total bacterial load of all participants was 5.22×107 cfu/mL. Azithromycin treatment resulted in a non-significant reduction in sputum neutrophil proportion, CXCL8 levels and bacterial load. "
06/01/1996 - "influenzae persisted in one azithromycin-treated patient with acute bronchitis who was classed as clinically improved. "
05/11/2002 - "Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial."
10/01/2012 - "We identified a Moraxella catarrhalis strain with high-level resistance to azithromycin (MIC>256 mg l(-1)), NSH1, isolated from nasopharyngeal swab samples from an inpatient with acute bronchitis in a Japanese hospital in 2011 and determined its mechanism of macrolide-lincosamide resistance. "
02/01/2012 - "Three patients were started on azithromycin because of recurrent bronchitis and had no events afterwards. "

05/14/2005 - "Efficacy of live infectious bronchitis vaccines against a novel European genotype, Italy 02."
06/01/2007 - "The efficacy of an avian metapneumovirus vaccine applied simultaneously with infectious bronchitis and Newcastle disease virus vaccines to specific-pathogen-free chickens."
07/01/2009 - "Serological studies of infectious bronchitis vaccines against Japanese field isolates of homologous and heterologous genotypes."
07/01/1956 - "Study of some commercially available infectious bronchitis vaccines. "
01/01/2015 - "Progress and challenges toward the development of vaccines against avian infectious bronchitis."

10/01/1986 - "[A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis]."
01/01/1992 - "Cefaclor AF, at all three dose levels studies, was seen to be as safe as cefaclor in the treatment of acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis."
01/01/1992 - "Two prospective randomized, double-blind, parallel studies were carried out in Europe to compare cefaclor advanced formulation (cefaclor AF) with cefaclor in the treatment of acute bronchitis caused by susceptible pathogens. "
01/01/1992 - "A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis."
10/01/1986 - "From the above results, it has been concluded that S6472 taken twice daily is equivalent to CCL in effectiveness on bacterial bronchitis."

04/01/2010 - "EPs-7630 significantly reduces the severity of symptoms, leads to a more favourable course of the disease and a faster recovery from acute bronchitis compared with the placebo, and is well tolerated."
05/01/2008 - "In conclusion, EPs 7630 is superior to placebo in the treatment of acute bronchitis and leads to faster remission of bronchitis related symptoms."
01/01/2007 - "In conclusion, EPs 7630 is an effective and well tolerated treatment of acute bronchitis in adults, children and infants outside the strict indication for antibiotic treatment."
09/01/2012 - "African Geranium (EPs 7630), part 2: the efficacy of Pelargonium sidoides (EPs 7630) in the treatment of acute bronchitis in adults and children."
02/01/2007 - "The objective of this study was to examine the efficacy and safety of a herbal drug preparation from the roots of Pelargonium sidoides (EPs 7630) in the treatment of acute bronchitis in adults outside the very restricted indication for an antibiotic therapy. "

10/01/1984 - "Doxycycline is not beneficial in the treatment of acute bronchitis in otherwise healthy adults."
01/01/1987 - "Improvement occurred in 29 and failure in 5. In the doxycycline-treated bronchitis group 11 of 36 patients were cured, 22 improved and 1 failure occurred. "
09/01/1987 - "Doxycycline in acute bronchitis: a randomized double-blind trial."
10/01/1984 - "In a randomized trial, a one-week course of a frequently used antibiotic, doxycycline, was compared with one week of placebo in 74 otherwise healthy adults with acute bronchitis. "
01/01/1977 - "Doxycycline in bronchitis: results of a multicentre study."

02/01/2009 - "The 2 SFC 50/250 inhalers were well tolerated; the most frequently reported adverse event was bronchitis, reported by 12% of the patients in the RPID group and 9% of those in the Diskus group. "
01/01/2003 - "[Efficiency of medication nebulizers in the treatment of dust obstructive bronchitis]."
07/04/1990 - "Nebulizer bronchitis induced by bacteriostatic saline."
02/01/1954 - "[Bronchitis vaporizer supporter and mobile roentgenogram filer]."
03/01/2000 - "More attention to healthcare management of chronic bronchitis and emphysema is suggested, and improving inhaler and anti-smoking compliance might be important targets."

07/01/1999 - "The post-radiation course was complicated by a severe radiation bronchitis; the onset of platypnea-orthodeoxia signalled the development of severe bronchial stenosis that was transiently relieved, initially by dilatation, and later by stent placement, though the patient ultimately died of a pulmonary hemorrhage. "
12/01/1991 - "Complications were dislocation (1 x), occlusive tumor growth (1 x), granulations (1 x), suppurative bronchitis (2 x), growth of tissue through the wall of metallic stents (1 x) and restenosis by indurated secretions (2 x). "
04/01/2013 - "Her plastic bronchitis improved significantly in 3 months but slowly progressed after the stent fenestration. "
09/01/2005 - "Following cardiac catheterization to stent open the fenestration, the symptoms of plastic bronchitis resolved. "
04/01/2013 - "At her 8-month follow-up, stent fenestration remains open and she is currently under heart transplantation evaluation due to persistent plastic bronchitis. "

07/01/2007 - "The sputum was re-examined within eight weeks in 65 patients (27.4%), of whom 38 (58.5%) had resolution of the neutrophilic bronchitis after treatment with an antibiotic. "
08/01/2005 - "One patient improved after treatment as acute bronchitis with oral amoxicillin. "
03/15/1979 - "[Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)]."
08/01/1999 - "In all 12 patients with eosinophilic bronchitis, the cough improved after treatment with inhaled budesonide 400 micrograms twice daily, and in eight of these patients who had a follow-up sputum analysis, the eosinophil count decreased significantly, from 16.8% to 1.6%. "
07/01/2010 - "Airway macrophage median percentage of red-hued area in stained sputum cytospin preparations was assessed by means of image analysis from (1) subjects with mild-to-severe asthma, subjects with nonasthmatic eosinophilic bronchitis, and healthy control subjects; (2) subjects with eosinophilic severe asthma after treatment with prednisolone; and (3) subject with noneosinophilic asthma before corticosteroid withdrawal. "

01/01/2002 - "We studied a 6-year-old boy and a 2-year-old girl with bronchitis fibroplastica following Fontan operation. "
04/01/2015 - "Case control analyses compared patients with PLE and plastic bronchitis with uncomplicated control patients receiving the Fontan procedure. "
01/01/2015 - "Plastic bronchitis is a severe complication after a Fontan procedure, with an estimated incidence around 1-2% and poor prognosis. "
08/01/2014 - "Median age at Fontan operation was 2.7 years (range, 1.2 to 4.1 years), with median interval to plastic bronchitis presentation of 1.5 years (range, 9 days to 15.4 years). "
08/01/2014 - "Plastic bronchitis is a rare, potentially life-threatening complication after Fontan operation. "

09/01/2012 - "is widely used for the treatment of coughs, bronchitis and asthmatic disorders in traditional Chinese medicine. "
03/06/2012 - "is widely used for the treatment of cough, bronchitis and asthmatic disorders in the Traditional Chinese Medicine. "
05/10/2015 - "The Mahuang-Xingren herb-pair (MX), the combination of Herba Ephedrae (Mahuang in Chinese) and Semen Armeniacae Amarum (Xingren in Chinese), is a classical combination used in traditional Chinese Medicine to treat asthma and bronchitis. "
03/01/1998 - "Traditional Chinese medicine in treatment of bronchitis and bronchial asthma."
11/30/2013 - "White mustard (Sinapis alba L.), a traditional Chinese medicine, is widely used in China for clinical prevention and treatment of the common winter diseases of asthma and bronchitis by percutaneous administration in the summer. "